Global Antibiotic API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Antibiotic API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Antibiotics refer to a class of secondary metabolites with anti-pathogen or other activities produced by bacteria, fungi and other microorganisms or higher animals and plants during their lives. They are chemical substances that can interfere with the development of other living cells. Commonly used clinical antibiotics include extracts from microbial cultures and chemically synthesized or semi-synthetic compounds. This report only counts antibiotic raw materials, excluding various intermediates and penicillin industrial salts.

According to our (Global Info Research) latest study, the global Antibiotic API market size was valued at US$ 5516 million in 2023 and is forecast to a readjusted size of USD 5050 million by 2030 with a CAGR of -1.3% during review period.

Global core Antibiotic API manufacturers include UNITED LABORATORIES, RUIYING PIONEER PHARMACEUTICAL, RUIYING PIONEER PHARMACEUTICAL etc. The top 5 companies hold a share about 25%.Asia-Pacific is the largest market, with a share about 60%, followed by Europe and North America with the share about 18% and 8%.

This report is a detailed and comprehensive analysis for global Antibiotic API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Antibiotic API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (USD/Kg), 2019-2030

Global Antibiotic API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (USD/Kg), 2019-2030

Global Antibiotic API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (USD/Kg), 2019-2030

Global Antibiotic API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (USD/Kg), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Antibiotic API

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Antibiotic API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include UNITED LABORATORIES, North China Pharmaceutical, RUIYING PIONEER PHARMACEUTICAL, Centrient Pharmaceuticals, Aurobindo Pharma, Shyndec Pharmaceutical, Nectar Lifesciences, Harbin Pharmaceutical Group, ACS Dobfar, Novartis, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Antibiotic API market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Penicillins
Cephalosporins
Aminoglycosides
Tetracyclines
Quinolones
Macrolides
Lincomycins
Others

Market segment by Application
Oral Medicine
Injection Medicine

Major players covered
UNITED LABORATORIES
North China Pharmaceutical
RUIYING PIONEER PHARMACEUTICAL
Centrient Pharmaceuticals
Aurobindo Pharma
Shyndec Pharmaceutical
Nectar Lifesciences
Harbin Pharmaceutical Group
ACS Dobfar
Novartis
CSPC
QILU ANTIBIOTICS PHARMACEUTICAL
REYOUNG
Orchid Pharma
FUAN PHARMACEUTICAL
Dongying Pharmaceutical
FUKANG PHARMACEUTICAL
Medya Pharmaceutical
LUKANG PHARMACEUTICAL
Dawnrays Pharmaceutical
SALUBRIS
KELUN
HUAFANG PHARMACEUTICAL

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Antibiotic API product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Antibiotic API, with price, sales quantity, revenue, and global market share of Antibiotic API from 2019 to 2024.

Chapter 3, the Antibiotic API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Antibiotic API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Antibiotic API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Antibiotic API.

Chapter 14 and 15, to describe Antibiotic API sales channel, distributors, customers, research findings and conclusion.